BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34381448)

  • 1. The Ability of Porcine Reproductive and Respiratory Syndrome Virus Isolates to Induce Broadly Reactive Neutralizing Antibodies Correlates With
    Martínez-Lobo FJ; Díez-Fuertes F; Simarro I; Castro JM; Prieto C
    Front Immunol; 2021; 12():691145. PubMed ID: 34381448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge.
    Robinson SR; Rahe MC; Gray DK; Martins KV; Murtaugh MP
    Virus Res; 2018 Mar; 248():13-23. PubMed ID: 29408442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
    Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
    Park C; Oh Y; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly neutralizing antibodies against the rapidly evolving porcine reproductive and respiratory syndrome virus.
    Robinson SR; Li J; Nelson EA; Murtaugh MP
    Virus Res; 2015 May; 203():56-65. PubMed ID: 25845944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on heterologous protection between Japanese type 1 and type 2 porcine reproductive and respiratory syndrome virus isolates.
    Iseki H; Kawashima K; Takagi M; Shibahara T; Mase M
    J Vet Med Sci; 2020 Jul; 82(7):935-942. PubMed ID: 32448816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity against a Japanese local strain of porcine reproductive and respiratory syndrome virus decreases viremia and symptoms of a highly pathogenic strain.
    Iseki H; Kawashima K; Shibahara T; Mase M
    BMC Vet Res; 2021 Apr; 17(1):156. PubMed ID: 33849520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus.
    Kick AR; Amaral AF; Frias-De-Diego A; Cortes LM; Fogle JE; Crisci E; Almond GW; Käser T
    Front Immunol; 2021; 12():637613. PubMed ID: 33767705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent vaccination of pigs with type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) protects against type 1 PRRSV but not against type 2 PRRSV on dually challenged pigs.
    Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Res Vet Sci; 2015 Dec; 103():193-200. PubMed ID: 26679817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus.
    Goldeck D; Perry DM; Hayes JWP; Johnson LPM; Young JE; Roychoudhury P; McLuskey EL; Moffat K; Bakker AQ; Kwakkenbos MJ; Frossard JP; Rowland RRR; Murtaugh MP; Graham SP
    Front Immunol; 2019; 10():572. PubMed ID: 30972067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor and major envelope proteins of PRRSV play synergistic roles in inducing heterologous neutralizing antibodies and conferring cross protection.
    Li J; Li S; Qiu M; Li X; Li C; Feng B; Lin H; Zheng W; Zhu J; Chen N
    Virus Res; 2022 Jul; 315():198789. PubMed ID: 35487365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains.
    Sun D; Khatun A; Kim WI; Cooper V; Cho YI; Wang C; Choi EJ; Yoon KJ
    Vaccine; 2016 Aug; 34(36):4335-42. PubMed ID: 27406935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.